Bacteria engineered to treat metabolic diseases Grant US-11896627-B2 United States of America 13 Feb 2024
Bacteria engineered to treat a disease or disorder Grant US-11883439-B2 United States of America 30 Jan 2024
Bacteria engineered to treat diseases associated with hyperammonemia Grant US-11845964-B2 United States of America 19 Dec 2023
Microorganisms engineered to reduce hyperphenylalaninemia Grant US-11766463-B2 United States of America 26 Sep 2023
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or… Grant US-11685925-B2 United States of America 27 Jun 2023
Bacteria engineered to reduce hyperphenylalaninemia Grant US-11618894-B2 United States of America 04 Apr 2023
BACTERIA ENGINEERED TO REDUCE HYPERPHENYLALANINEMIA Application EP-4095150-A1 European Patent Office 30 Nov 2022
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or… Grant US-11384359-B2 United States of America 12 Jul 2022
ENGINEERED PROBIOTIC BACTERIA FOR PREBIOTIC-RESPONSIVE CONTROL OF COLONIZATION Application WO-2022013269-A1 World Intellectual Property Organisation (WIPO) 20 Jan 2022
BACTERIA ENGINEERED TO TREAT DISEASES ASSOCIATED WITH HYPERAMMONEMIA Application EP-3940067-A1 European Patent Office 19 Jan 2022
BACTERIA ENGINEERED TO REDUCE HYPERPHENYLALANINEMIA Application EP-3882259-A1 European Patent Office 22 Sep 2021
Bacteria engineered to treat diseases associated with hyperammonemia Grant US-11060073-B2 United States of America 13 Jul 2021
Bacteria engineered to treat a disease or disorder Grant US-10933102-B2 United States of America 02 Mar 2021
Bacteria engineered to reduce hyperphenylalaninemia Grant US-10610546-B2 United States of America 07 Apr 2020
ENGINEERED BACTERIA EXPRESSING RACEMASE FOR TREATING DISEASES ASSOCIATED WITH… Application WO-2019090101-A1 World Intellectual Property Organisation (WIPO) 09 May 2019
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or… Grant US-10273489-B2 United States of America 30 Apr 2019
Bacteria engineered to reduce hyperphenylalaninemia Grant US-10195234-B2 United States of America 05 Feb 2019
BACTERIA ENGINEERED TO TREAT METABOLIC DISEASES Application US-20190010506-A1 United States of America 10 Jan 2019
Probiotic Bifidobacterium adolescentis strains Grant US-10022408-B2 United States of America 17 Jul 2018
Bacteria engineered to reduce hyperphenylalaninemia Grant US-9943555-B2 United States of America 17 Apr 2018
Bacteria engineered to treat diseases associated with hyperammonemia Grant US-9688967-B2 United States of America 27 Jun 2017
BACTERIA ENGINEERED TO REDUCE HYPERPHENYLALANINEMIA Application WO-2017087580-A1 World Intellectual Property Organisation (WIPO) 26 May 2017
MULTI-LAYERED CONTROL OF GENE EXPRESSION IN GENETICALLY ENGINEERED BACTERIA Application WO-2016210378-A2 World Intellectual Property Organisation (WIPO) 29 Dec 2016
BACTERIA ENGINEERED TO TREAT DISEASES ASSOCIATED WITH HYPERAMMONEMIA Application WO-2016200614-A2 World Intellectual Property Organisation (WIPO) 15 Dec 2016
Bacteria engineered to treat diseases associated with hyperammonemia Grant US-9487764-B2 United States of America 08 Nov 2016
PROBIOTIC BACTERIA AS CARRIER FOR A HELMINTH-DERIVED IMMUNOMODULATOR FOR THE TREATMENT OF… Application WO-2014037505-A1 World Intellectual Property Organisation (WIPO) 13 Mar 2014